BioWorld

Nov. 19, 2018

View Archived Issues

BioWorld stock report for public biotechnology companies

Read More

This week's biggest gainers and losers

Read More

Regulatory submissions, approvals and other actions: October 2018

Read More

Conference data: October 2018

Read More

Word on the street

Read More

Week in Washington

Read More

Week in review

Read More

Biopharma money raised Jan. 1 - Nov. 14

Read More

Biotech products surge thanks to big pharma spending

Biological drugs – monoclonal antibodies, peptides, recombinant proteins and the like – now account for more than 30 percent of all FDA approvals according to a new study from the Tufts Center for the Study of Drug Development. Read More

Money raised by biotech: 2018 vs. 2017

Read More